|
AU2018215619A1
|
|
Alpha-MSH analogues used in the treatment of xeroderma pigmentosum
|
|
EP2487185A1
|
|
Hexapeptide with improved activity in the repair of cellular DNA of dermal cells
|
|
EP2957292A1
|
|
Therapy for vitiligo
|
|
EP2259794A1
|
|
Method for treatment of photosensitivity and phototoxicity
|
|
AU2007291886A1
|
|
Method of treatment of photodermatoses
|
|
NZ575134A
|
|
Method for reducing incidence or rate of development of skin cancers and related conditions using alpha-msh analogue
|
|
CN101076348A
|
|
Compositions and methods for inducing melanogenesis in a subject
|
|
AU2005269244A1
|
|
Methods of inducing melanogenesis in a subject.
|
|
AU2004290470A1
|
|
A method of inducing melanogenesis in humans with MC1R variant alleles
|
|
NZ547383A
|
|
A method of inducing melanogenesis in humans with MC1R variant alleles
|
